JP6669822B2 - Fermentation method of the combination of Thermos thermophilus and yeast - Google Patents
Fermentation method of the combination of Thermos thermophilus and yeast Download PDFInfo
- Publication number
- JP6669822B2 JP6669822B2 JP2018150901A JP2018150901A JP6669822B2 JP 6669822 B2 JP6669822 B2 JP 6669822B2 JP 2018150901 A JP2018150901 A JP 2018150901A JP 2018150901 A JP2018150901 A JP 2018150901A JP 6669822 B2 JP6669822 B2 JP 6669822B2
- Authority
- JP
- Japan
- Prior art keywords
- yeast
- fermentation
- culture
- thermophilus
- rpm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims description 151
- 230000004151 fermentation Effects 0.000 title claims description 150
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 93
- 238000000034 method Methods 0.000 title claims description 41
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 92
- 241000589499 Thermus thermophilus Species 0.000 claims description 24
- 230000003698 anagen phase Effects 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 23
- 238000012258 culturing Methods 0.000 claims description 23
- 230000012010 growth Effects 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 18
- 238000003860 storage Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 6
- 241000051160 Thermus thermophilus HB27 Species 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 210000005253 yeast cell Anatomy 0.000 claims description 3
- 230000001877 deodorizing effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 80
- 239000000047 product Substances 0.000 description 75
- 230000000694 effects Effects 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 40
- 238000005273 aeration Methods 0.000 description 31
- 230000001580 bacterial effect Effects 0.000 description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 26
- 238000012360 testing method Methods 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 25
- 239000000203 mixture Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000000306 component Substances 0.000 description 18
- 230000003110 anti-inflammatory effect Effects 0.000 description 17
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 241000894007 species Species 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 14
- 206010000496 acne Diseases 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 235000019156 vitamin B Nutrition 0.000 description 14
- 239000011720 vitamin B Substances 0.000 description 14
- 208000002874 Acne Vulgaris Diseases 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 230000007423 decrease Effects 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 239000001888 Peptone Substances 0.000 description 10
- 108010080698 Peptones Proteins 0.000 description 10
- 239000013543 active substance Substances 0.000 description 10
- 239000003513 alkali Substances 0.000 description 10
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 10
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 10
- 235000011130 ammonium sulphate Nutrition 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 description 10
- 235000019319 peptone Nutrition 0.000 description 10
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 230000002757 inflammatory effect Effects 0.000 description 9
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 230000000975 bioactive effect Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 210000002510 keratinocyte Anatomy 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 101100377299 Arabidopsis thaliana ZHD13 gene Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229930003270 Vitamin B Natural products 0.000 description 6
- 239000012670 alkaline solution Substances 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000005909 Kieselgur Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000008029 eradication Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 235000019645 odor Nutrition 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000003501 co-culture Methods 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- 229960003957 dexamethasone Drugs 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 238000004383 yellowing Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 108090001007 Interleukin-8 Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102100040247 Tumor necrosis factor Human genes 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012747 synergistic agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Birds (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、化粧品発酵原材料分野に属し、特にサーマス・サーモフィラスと酵母菌との組合せの発酵方法および応用に関する。 The present invention relates to the field of cosmetic fermentation raw materials, and more particularly to a fermentation method and application of a combination of Thermos thermophilus and yeast.
生物発酵原材料は、化粧品分野における応用が日々増えており、ここ数年、酵素化粧品は消費者から高い人気を集めている。発酵は純粋な生物的過程であり、如何なる化学成分も添加されていない。発酵は生理活性物質をさらに溶出しやすくし、発酵によって全ての活性成分を抽出することは、新しい栄養素を生成し、栄養成分のバランスを一層良くし、栄養成分を低分子化し、活性をさらに強くさせ、皮膚に迅速に吸収されることができる。発酵微生物自身には様々な酵素や微量元素が含まれており、補充および相乗効果を有する。そのため、消費者の「天然、健康、高効率」スキンケア用品に対する期待に合致している。 The application of biofermented raw materials in the cosmetics field is increasing day by day, and in recent years, enzyme cosmetics have been highly popular with consumers. Fermentation is a purely biological process, with no added chemical components. Fermentation makes it easier to elute physiologically active substances, and extracting all active ingredients by fermentation creates new nutrients, improves the balance of nutrients, lowers the molecular weight of nutrients, and enhances activity And can be quickly absorbed by the skin. The fermenting microorganism itself contains various enzymes and trace elements and has a replenishing and synergistic effect. Therefore, it meets the expectations of consumers for “natural, healthy, and highly efficient” skin care products.
酵母菌は、現在、化粧品発酵原材料分野において最も応用されている菌株であり、酵母抽出物は天然、安全、強力な保湿効果を有する。酵母細胞には豊富な天然保湿因子(NMF)、例えば、アミノ酸、ペプチド系、ナトリウム、カリウム、マグネシウムなどの無機成分が含有されている。ここで、アミノ酸は天然保湿因子(NMF)の40%を占め、ナトリウム、カリウム、マグネシウムなどの無機成分は天然保湿因子(NMF)の12%を占める。酵母細胞壁の主要成分は、酵母β−(1,3)/(1,6)−グルカンおよびマンナンM60を含む。酵母β−(1,3)/(1,6)−グルカンは、大量の親水基を含み、水分を吸収かまたは皮膚角質層の水分を保持することができる。酵母マンナンM60の固有の分子構造は水分子を保持することができ、長時間保湿する作用を果たす。例えば、中国の特許出願公開番号CN105434319A、CN107184411A、CN10655182Aの特許文献には、酵母発酵生成物を化粧品の原材料として化粧品を製造することが開示されている。 Yeast is currently the most applied strain in the field of cosmetic fermentation raw materials, and yeast extract has a natural, safe and strong moisturizing effect. Yeast cells contain abundant natural moisturizing factors (NMF), for example, amino acids, peptide systems, and inorganic components such as sodium, potassium, and magnesium. Here, amino acids account for 40% of the natural moisturizing factor (NMF), and inorganic components such as sodium, potassium and magnesium account for 12% of the natural moisturizing factor (NMF). The main components of the yeast cell wall include yeast β- (1,3) / (1,6) -glucan and mannan M60. Yeast β- (1,3) / (1,6) -glucan contains a large amount of hydrophilic groups and can absorb water or retain water in the stratum corneum of the skin. The unique molecular structure of yeast mannan M60 is capable of retaining water molecules and has a long-term moisturizing action. For example, Chinese Patent Application Publication Nos. CN105543319A, CN107184411A, and CN10655182A disclose the production of cosmetics using a yeast fermentation product as a raw material of cosmetics.
サーマス・サーモフィラス(Thermus Thermophilus)は好熱性細菌であり、熱安定性のあるスーパーオキシドディスムターゼ(SOD)およびビタミンB群を生成することができる。スーパーオキシドディスムターゼは、O2 −をH2O2に酸化し、生体が酸化により損傷されることを回避することができ、皮膚に対する遊離基の侵害を防止ぐことで、老化を防止する効力を果たす。ビタミンB群は、皮膚の炎症反応を軽減し、日光によるダメージを防止し、細胞の再生を促進することができる。ビタミンB群は、さらに、様々な酵素や補酵素の分子構造の一部分であり、皮膚の健康を維持するためにアミノ酸代謝を促進することができる。中国の特許出願番号2017107329367の特許文献にも、サーマス・サーモフィラスの発酵生成物をスキンケア成分として採用することが開示されているが、該スキンケア成分は、サーマス・サーモフィラスの発酵生成物以外に、組み換えヒトコラーゲンをさらに含んでいる。しかしながら、該特許文献ではサーマス・サーモフィラスの発酵生成物しか言及されておらず、いかに発酵するかについては開示していない。また、例えば、中国の特許出願、出願番号200710031387の特許文献にも生体酵素による日焼け止め組成物が開示され、該組成物はサーマス・サーモフィラスの生体酵素を含み、また、その割合が提供されている。しかしながら、一般的なサーマス・サーモフィラスはいずれも発酵によって生成されており、酵素の活性または酵素の産出量については開示されておらず、さらにこのような酵素が他の成分と組み合わせる際、安定性も重要な要因の1つである。日焼け止め製品には酵素が含まれているため、酵素が紫外線の影響を受けて不活性化になるか否か、酵素の活性を有するか否かについても不確定である。 Thermus Thermophilus is a thermophilic bacterium that can produce thermostable superoxide dismutase (SOD) and B vitamins. Superoxide dismutase can oxidize O 2 − to H 2 O 2 , avoid damage to the living body by oxidation, and prevent aging by preventing free radical invasion of the skin. Fulfill. B vitamins can reduce the inflammatory response of the skin, prevent sun damage and promote cell regeneration. B vitamins are also part of the molecular structure of various enzymes and coenzymes and can promote amino acid metabolism to maintain skin health. Chinese Patent Application No. 2017107329367 also discloses that the fermented product of Thermos thermophilus is used as a skin care component, but the skin care component is a recombinant human fermented product other than the fermented product of Thermos thermophilus. It also contains collagen. However, the patent document only mentions a fermentation product of Thermos thermophilus and does not disclose how to ferment. In addition, for example, the patent document of Chinese patent application No. 20070031387 also discloses a sunscreen composition using a bioenzyme, which composition contains a bioenzyme of Thermos thermophilus, and its ratio is provided. . However, all common Thermos thermophilus are produced by fermentation, and no disclosure is made regarding the activity of the enzyme or the yield of the enzyme, and furthermore, when such an enzyme is combined with other components, the stability is also low. This is one of the important factors. Since sunscreen products contain enzymes, it is also uncertain whether the enzymes will be inactivated by the effects of ultraviolet light or have the activity of the enzymes.
従来技術では、いずれも単一菌種をそれぞれ発酵させた後、2種類の発酵液を混合している。異なる菌叢や酵素類がともに溶解されて中和反応を引き起こすことにより、大量の菌叢や酵素の活性が損失されるため、実際の効果は好ましくないことが多い。よって、従来の発酵方法および生成物を改良しなければならず、更なる生理活性物質を取得し、単一発酵生成物の混合による相互作用および中和効果の減少が期待されている。 In the prior art, two types of fermented liquids are mixed after fermenting a single bacterial species. When the different flora and enzymes are dissolved together to cause a neutralization reaction, a large amount of the activities of the flora and enzymes are lost, so that the actual effect is often undesirable. Therefore, it is necessary to improve the conventional fermentation method and product, to obtain a further bioactive substance, and to reduce the interaction and the neutralization effect by mixing a single fermentation product.
上記問題を解決するために、本発明はサーマス・サーモフィラスおよび酵母菌の組合せの発酵工程を提供することによってサーマス・サーモフィラス発酵生成物の生理活性を向上させ、サーマス・サーモフィラス発酵生成物の適用効果を豊富にする目的を達成し、特に、サーマス・サーモフィラス発酵生成物の穏やかな抗炎症における効果を向上させ、化粧品の「天然、健康、高効率」に対する追及を満たす。 In order to solve the above-mentioned problems, the present invention provides a fermentation process of a combination of a Thermos thermophilus and a yeast, thereby improving the physiological activity of the Thermos thermophilus fermentation product and improving the application effect of the Thermos thermophilus fermentation product. Achieving the enrichment objectives, in particular, improving the effect of the Thermus thermophilus fermentation product on mild anti-inflammatory and fulfilling the pursuit of "natural, healthy, high efficiency" of cosmetics.
本発明の発明者らは、複数菌共生発酵により複数種類の菌を制御可能に発酵させれば、さらに多種類の有益な酵素を発酵させることができるだけでなく、各種類の酵素の産出量を一般的な単一菌種の発酵量の数倍にさせることができることを見出した。酵素が多いほど、人体に対する触媒健康管理機能は強い。市場においては酵母抽出物およびサーマス・サーモフィラス発酵生成物が市販されているが、いずれも単一製品として化粧品に添加されており、酵母菌およびサーマス・サーモフィラスの組合せによる発酵を開拓して化粧品に用いることは新しい課題である。 The inventors of the present invention can control not only fermentation of a variety of useful enzymes but also yield of each type of enzyme by fermentation of a plurality of types of bacteria in a controllable manner by co-fermentation of a plurality of bacteria. It has been found that the fermentation amount can be several times the fermentation amount of a general single strain. The more enzymes, the stronger the catalytic health care function for the human body. Yeast extract and Thermos thermophilus fermentation products are marketed on the market, but both are added to cosmetics as a single product, and fermentation by combination of yeast and Thermos thermophilus is used to develop cosmetics That is a new challenge.
また、本発明の発明者らは、酵母および好熱性細菌を共培養させ、特別な培養工程によれば、酵母の好熱性細菌に対する培養に活性化誘発性作用を果すようにすることができ、単独で好熱性細菌を培養することによって得られる生成物の活性に比べて顕著に向上され、一方で酵母自身の培養製品の活性にはそれほど大きな影響を与えていないことを見出した。よって、好熱性細菌の生理活性物質の放出を強化させ、または生理活性物質の活性を強化している。 Further, the inventors of the present invention can co-cultivate yeast and thermophilic bacteria, and according to a special culturing step, it is possible to exert an activation-inducing effect on the culture of yeast against thermophilic bacteria, It has been found that the activity of the product obtained by culturing the thermophilic bacterium alone is remarkably improved, while the activity of the culture product of the yeast itself is not significantly affected. Therefore, the release of the physiologically active substance of the thermophilic bacterium is enhanced, or the activity of the physiologically active substance is enhanced.
好熱性細菌を単独で培養することにより一部の有益な生理活性物質を生成することができるが、このような生理活性物質の量は非常に少なく、活性も高くない。酵母および好熱性細菌を共培養させる場合、特別な培養方法によれば、好熱性細菌の生理活性物質を顕著に向上させることができる製品を見出し、特に一部の生理活性物質の活性が顕著に強化されていることを見出した。 Some useful bioactive substances can be produced by culturing thermophilic bacteria alone, but the amount of such bioactive substances is very small and the activity is not high. When yeast and thermophilic bacteria are co-cultured, according to a special culture method, a product that can significantly improve the physiologically active substance of the thermophilic bacterium is found, and in particular, the activity of some physiologically active substances is remarkably increased. Found that it has been strengthened.
また、本発明は好熱性細菌の発酵生成物を培養する方法を提供し、該方法は、
サッカロマイセス・セレビシエを中温、酸性条件において1回または複数回発酵させ、酵母菌を増殖させるステップ(1)と、酵母菌が後期対数増殖期になってから温度を昇温させた後の0日または1日後に、サーマス・サーモフィラスを接種し、アルカリ条件において第2回発酵を行い、発酵生成物を得るステップ(2)と、を含む。
The present invention also provides a method of culturing a fermentation product of a thermophilic bacterium, the method comprising:
Fermenting Saccharomyces cerevisiae one or more times under acidic conditions at medium temperature to grow the yeast (1); and 0 days after the temperature is increased after the yeast has reached the late logarithmic growth phase. One day later, inoculating a Thermus thermophilus and performing a second fermentation under alkaline conditions to obtain a fermentation product (2).
一部の好ましい形態において、酵母に対して、少なくとも2回の増殖培養、または少なくとも3回、または少なくとも4回、5回、6回の増殖培養を行うことにより、酵母を対数増殖期にさせる。 In some preferred forms, the yeast is subjected to at least two growth cultures, or at least three, or at least four, five, or six growth cultures, to bring the yeast to a logarithmic growth phase.
一部の好ましい形態において、サーマス・サーモフィラスに対して、混合発酵させる前にも1回または複数回の増殖培養を行う。 In some preferred embodiments, the Thermus thermophilus is subjected to one or more growth cultures prior to mixed fermentation.
一部の好ましい形態において、該方法は、ステップ(2)の発酵液に対して除菌、脱色、脱臭、濾過による不純物除去を行い、サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を得るステップ(3)をさらに含む。 In some preferred embodiments, the method comprises subjecting the fermentation liquor of step (2) to sterilization, decolorization, deodorization, and removal of impurities by filtration to obtain a fermentation product by a combination of Thermos thermophilus and yeast. (3) is further included.
一部の好ましい形態において、前記サッカロマイセス・セレビシエの菌株はCICC1596であり、中国工業微生物菌種保存管理センターから購入され、保存番号はCICC1596である。 In some preferred embodiments, the Saccharomyces cerevisiae strain is CICC1596, purchased from the China Center for the Preservation and Control of Microbial Species, and has the storage number of CICC1596.
一部の好ましい形態において、本発明において使用されるサーマス・サーモフィラスHB27はアメリカン・タイプ・カルチャー・コレクション(ATCC)から購入され、保存番号はBAA−163である。 In some preferred forms, Thermus thermophilus HB27 used in the present invention is purchased from the American Type Culture Collection (ATCC) and has a storage number BAA-163.
一部の形態において、酵母に対して低温培養を行い、温度は20℃〜30℃である。 In some embodiments, the yeast is subjected to low-temperature culturing and the temperature is between 20C and 30C.
一部の形態において、酵母に対して酸性領域で培養を行い、pH値は4.0〜5.0である。 In some embodiments, the yeast is cultured in an acidic region and has a pH value of 4.0 to 5.0.
一部の形態において、酵母菌が後期対数増殖期になってから0日または1日後に昇温させ始める。好ましくは、温度を55℃〜75℃、または60℃〜65℃まで昇温させる。または60℃、65℃、70℃、58℃、61℃まで昇温させる。低温から高温まで昇温させる時間は、一般的に数分間かかり、例えば、電気加熱の方法により昇温させる。 In some forms, the yeast begins to heat up 0 or 1 day after the late log phase. Preferably, the temperature is raised to 55 ° C to 75 ° C, or to 60 ° C to 65 ° C. Alternatively, the temperature is raised to 60 ° C, 65 ° C, 70 ° C, 58 ° C, and 61 ° C. The time required to raise the temperature from a low temperature to a high temperature generally takes several minutes. For example, the temperature is raised by an electric heating method.
一部の形態において、温度を昇温させてから0日または1日後に、好熱性細菌を接種し始め、同時にまたは接種後1日から培地のpH値をアルカリ性に調整し、pH値は7.0〜8.5である。 In some embodiments, 0 or 1 day after the temperature is increased, the inoculation of the thermophilic bacterium is started, and at the same time or 1 day after the inoculation, the pH value of the medium is adjusted to alkaline. 0 to 8.5.
一部の形態において、二次発酵の条件は、通気量が5m3/h/50L〜10m3/h/50Lに維持され、100rpm〜200rpm、発酵日数は1〜3日である。 In some embodiments, the condition of the secondary fermentation, aeration is maintained 5m 3 / h / 50L~10m 3 / h / 50L, 100rpm~200rpm, fermentation days is 1-3 days.
一部の形態において、前記酵母の拡大培養方法は、クリーンベンチに試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ(接種ループを使用し1回で採取できる菌液の量)を取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに入れ、200rpm(1分間ごとに200回転)、30℃で10hほど培養し、菌体を対数増殖期にさせるステップ(1)と、対数増殖期にある菌体を2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積百分率、200ミリリットルのステップ(1)の対数増殖期にある酵母培養液)とし、200rpm、30℃で10hほど培養するステップ(2)と、ステップ(2)で培養された3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養するステップ(3)と、30Lの菌液を300Lが入った二級種の500Lタンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養するステップ(4)と、を含む。 In some embodiments, the method for expanding the yeast comprises removing one loop of Saccharomyces cerevisiae CICC1596 (the amount of bacterial solution that can be collected at one time using the inoculation loop) on a test tube slope on a clean bench, and adding 50 ml of the yeast. A step (1) of placing in a 250 ml Erlenmeyer flask containing a culture solution (pH 4.8 ± 0.2), culturing at 200 rpm (200 rotations per minute) at 30 ° C. for about 10 hours, and allowing the cells to enter a logarithmic growth phase (1) ) And the cells in the logarithmic growth phase are inoculated into a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and the inoculum is increased to 10% (volume percentage, 200 ml step (1)). (2) culturing at 200 rpm and 30 ° C. for about 10 hours, and 3 L of the bacterial species cultivated in step (2) are subjected to a 30 L fermentation liquid ( a step (3) of inoculating a 50L tank of a first-class species containing (pH 4.8 ± 0.2), maintaining the aeration at 5 m 3 / h / 50 L, and culturing at 200 rpm for 10 hours at 30 ° C .; (4) transferring the bacterial solution to a second-class 500 L tank containing 300 L, maintaining the aeration at 5 m 3 / h / 50 L, and culturing at 200 rpm, 30 ° C. for about 10 h.
さらに、本発明は下記のステップを含む方法を提供する。
(ステップ1)
サッカロマイセス・セレビシエおよびサーマス・サーモフィラスに対してそれぞれ増殖培養を行う。
ここで、サッカロマイセス・セレビシエの増殖方法は下記の通りである。
(1)クリーンベンチに試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに入れ、200rpm(1分間ごとに200回転)、30℃で10hほど培養し、菌体を対数増殖期にさせる;
(2)対数増殖期にある菌体を2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積百分率、200ミリリットルのステップ(1)の対数増殖期にある酵母培養液)とし、200rpm、30℃で10hほど培養する;
(3)ステップ(2)で培養された3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する;
(4)30Lの菌液を300Lが入った二級種の500Lタンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する。
また、サーマス・サーモフィラスの増殖方法は下記の通りである。
クリーンベンチにサーマス・サーモフィラスHB27の凍結溶液を2ml取り、2Lの培養液(pH7.8±0.2)が入った2.5L三角フラスコに接種し、通気量を5m3/h/50Lに維持し、150rpm、65℃で12hほど培養し、菌体が対数増殖期になってから、30Lの菌液を300Lの培養液が入った二級種の500Lタンクに接種する。
(ステップ2)
酵母に対する一次発酵方法は下記の通りである。
300Lの二級種タンク内の(ステップ(4)の後の)酵母菌培養液を2400Lの培養液(pH4.8±0.2)が入った5000Lの発酵タンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で14hほど培養する。
(ステップ3)
2次発酵として、一次発酵(ステップ2)の培養液の温度を30℃から65℃に昇温させた後、温度が65℃に昇温した後(0日)、すぐ300Lのサーマス・サーモフィラス増殖液をこの発酵タンクに移し、通気量を5m3/h/50Lに維持し、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養する。
Further, the present invention provides a method including the following steps.
(Step 1)
Growth culture is performed on Saccharomyces cerevisiae and Thermus thermophilus, respectively.
Here, the propagation method of Saccharomyces cerevisiae is as follows.
(1) Take 1 loop of Saccharomyces cerevisiae CICC1596 on the test tube slope in a clean bench, put it in a 250 ml Erlenmeyer flask containing 50 ml of culture solution (pH 4.8 ± 0.2), and put 200 rpm (200 per minute). (Rotation), culturing at 30 ° C. for about 10 h to allow the cells to reach a logarithmic growth phase;
(2) The cells in the logarithmic growth phase are inoculated into a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and the inoculum amount is increased by 10% (volume percentage, 200 ml step (1)). Yeast culture in a logarithmic growth phase), and cultured at 200 rpm and 30 ° C. for about 10 hours;
(3) 3 L of the bacterial species cultured in step (2) is inoculated into a first-class 50 L tank containing 30 L of fermentation broth (pH 4.8 ± 0.2), and the aeration rate is 5 m 3 / h / 50 L. And culture at 200 rpm, 30 ° C. for about 10 h;
(4) Transfer 30 L of the bacterial solution to a 500 L tank of a second grade containing 300 L, maintain the aeration at 5 m 3 / h / 50 L, and incubate at 200 rpm, 30 ° C. for about 10 h.
The method of multiplying Thermos thermophilus is as follows.
Take 2 ml of a frozen solution of Thermos thermophilus HB27 in a clean bench, inoculate it into a 2.5 L Erlenmeyer flask containing 2 L of culture solution (pH 7.8 ± 0.2), and maintain the aeration at 5 m 3 / h / 50 L. Then, the cells are cultured at 150 rpm and 65 ° C. for about 12 hours, and after the cells have reached the logarithmic growth phase, 30 L of the bacterial solution is inoculated into a 500 L tank of a secondary species containing 300 L of the culture solution.
(Step 2)
The primary fermentation method for yeast is as follows.
The yeast culture (after step (4)) in the 300 L secondary seed tank was transferred to a 5000 L fermentation tank containing 2400 L culture (pH 4.8 ± 0.2) and the aeration was 5 m 3. / H / 50L, and culture at 200 rpm and 30 ° C for about 14 hours.
(Step 3)
As the secondary fermentation, the temperature of the culture solution of the primary fermentation (step 2) is raised from 30 ° C. to 65 ° C., and after the temperature is raised to 65 ° C. (day 0), 300 L of Thermos thermophilus is immediately expanded. The solution was transferred to this fermentation tank, the aeration was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, the pH was adjusted to 7.8 ± 0.2 with an alkaline solution, and the solution was stirred at 150 rpm at 65 ° C. for about 18 hours. Incubate.
一部の好ましい形態において、培養液の配合成分は、20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムについて、pH値を酸またはアルカリで調整および制御し、水を20Lまで補充する。異なる量の培養液は、配合例に従って増減する。 In some preferred embodiments, the composition of the culture broth is a 20 L culture broth comprising 60 g peptone, 4 g wort, 7 g anhydrous magnesium sulfate, 2.4 g potassium dihydrogen phosphate, 40 g ammonium sulfate, For 1 g of anhydrous iron chloride and 5 g of sodium chloride, the pH value is adjusted and controlled with an acid or alkali and the water is replenished to 20 L. Different amounts of culture solution will increase or decrease according to the formulation.
また、好熱性細菌および酵母の共生発酵培養による発酵生成物の皮膚の消炎または皮膚の保湿の試薬の製造における用途であって、前記好熱性細菌および酵母の共生発酵の方法は、まず、低温、酸性において、酵母に対して1回または複数回の液体増殖発酵を行い、対数増殖期になるようにし、その後、発酵液の温度を低温から高温に変化させた後の0日または1日後に、サーマス・サーモフィラスを添加して二次発酵を行い、発酵条件をアルカリ条件にする、ことを含む。 Further, it is an application in the manufacture of a reagent for skin anti-inflammatory or skin moisturization of a fermentation product by a symbiotic fermentation culture of a thermophilic bacterium and a yeast. In acid, the yeast is subjected to one or more liquid growth fermentations to allow for a logarithmic growth phase, and then 0 or 1 day after changing the temperature of the fermentation liquor from low to high, Secondary fermentation is performed by adding Thermos thermophilus, and fermentation conditions are set to alkaline conditions.
好ましくは、前記発酵方法は上述したいずれかの発酵方法である。 Preferably, the fermentation method is any of the fermentation methods described above.
一部の好ましい形態において、前記試薬は化粧品試薬であり、用途は例えば、スキンケア試薬における用途である。 In some preferred embodiments, the reagent is a cosmetic reagent, and the use is, for example, in a skin care reagent.
また、本発明に係る試薬であって、該試薬は皮膚の経皮水分の流出を低下させることができ、該試薬は本発明に係る方法により得られる発酵生成物の混合物を含む。 Also, a reagent according to the present invention, which is capable of reducing the outflow of transdermal water from the skin, said reagent comprising a mixture of fermentation products obtained by the method according to the present invention.
一部の好ましい形態において、前記用途または試薬において、好熱性細菌はサーマス・サーモフィラスHB27であり、アメリカン・タイプ・カルチャー・コレクション(ATCC)から購入され、保存番号はBAA−163である。 In some preferred forms, in the use or reagent, the thermophilic bacterium is Thermus thermophilus HB27, purchased from the American Type Culture Collection (ATCC), and has the storage number BAA-163.
一部の好ましい形態において、前記酵母はCICC1596であり、中国工業微生物菌種保存管理センターから購入され、保存番号はCICC1596である。 In some preferred embodiments, the yeast is CICC1596, purchased from the Center for the Preservation and Control of Microbial Species of China, and has the storage number of CICC1596.
他の一部の好ましい形態において、上記試薬は、発酵生成物以外に、他の成分をさらに含むことができ、例えば、その他の化粧試薬の成分、例えば、フルーツオイル、シリコーンオイル、ステアリン酸グリセリル、キサンタンガム、純水などその他の成分を添加してもよい。さらに例えば、純水、Tween−80、プロパンジオール、防腐剤などを含む配合されたセラムを添加してもよい。本発明の発酵生成物の混合物に対する一部の体外および人体試験によって、本発明の発酵生成物は、単一の酵母発酵生成物、好熱性細菌発酵生成物および発酵混合した後の試薬に対して顕著な改善作用を有し、これは、2種類の菌の共培養は互いに促進作用を有し、生理活性物質の活性の含有量または活性はいずれも大幅に向上されることを説明しているようである。 In some other preferred embodiments, the reagent may further include other components in addition to the fermentation product, such as components of other cosmetic reagents, such as fruit oil, silicone oil, glyceryl stearate, Other components such as xanthan gum and pure water may be added. Further, for example, a blended serum containing pure water, Tween-80, propanediol, a preservative and the like may be added. According to some in vitro and human studies on the mixture of fermentation products of the present invention, the fermentation products of the present invention can be used for single yeast fermentation products, thermophilic bacterial fermentation products and reagents after fermentation mixing. It has a remarkable ameliorating effect, which explains that the co-cultivation of the two types of bacteria has a stimulating effect on each other, and both the content or activity of the activity of the physiologically active substance is greatly improved. It seems.
また、本発明は、酵母およびサーマス・サーモフィラスを共同で培養させる際、サーマス・サーモフィラスによるビタミンB群の生成量を実質的に変えていないが、一部の生理活性物質の生成が促進され、このような生理活性物質はビタミンB群の活性を向上させることができることを見出した。そのため、本発明は、酵母をサーマス・サーモフィラスによりビタミンB群を生成することを促進する生理活性物質とする新しい用途を提供する。そのため、本発明は、菌株がCICC1596であるサッカロマイセス・セレビシエをHB27菌株のサーマス・サーモフィラスが、B群微生物を強化する生理活性物質を生成する発酵の共力剤とする用途を提供する。 In addition, the present invention does not substantially change the amount of vitamin B group produced by Thermos thermophilus when co-cultivating yeast and Thermomus thermophilus, but promotes the production of some physiologically active substances. It has been found that such a physiologically active substance can improve the activity of the vitamin B group. Therefore, the present invention provides a new use of yeast as a physiologically active substance that promotes the production of B vitamins by Thermos thermophilus. Therefore, the present invention provides the use of Saccharomyces cerevisiae, whose strain is CICC1596, as a synergistic agent for fermentation in which the HB27 strain Thermus thermophilus produces a bioactive substance that enhances group B microorganisms.
生体外実験結果によれば、サーマス・サーモフィラスおよびサッカロマイセス・セレビシエの組合せによる発酵生成物は単一のサーマス・サーモフィラスの発酵生成物に比べて皮膚線維芽細胞の成長を促進する能力がさらに強く、3%の濃度で皮膚線維芽細胞の成長率を20%ほど向上させることができることが明らかになった。 According to in vitro experimental results, the fermentation product of the combination of Thermos thermophilus and Saccharomyces cerevisiae has a stronger ability to promote the growth of dermal fibroblasts than the fermentation product of a single Thermos thermophilus. It was found that at a concentration of%, the growth rate of skin fibroblasts could be improved by as much as 20%.
サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物は単一のサーマス・サーモフィラスの発酵生成物に比べて消炎効果がさらに強く、皮膚角質細胞は炎症作用の刺激を受ける場合、10%のサーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を添加すると、炎症因子IL−1α、IL−6、IL−8およびTNF−αの分泌が明らかに減少し、100ppmのデキサメタゾンの消炎効果に相当するが、デキサメタゾンより穏やかであり、消炎効果は10%の単一のサーマス・サーモフィラスの発酵生成物または単一の酵母発酵より明らかに優れている。 The fermented product of the combination of Thermos thermophilus and yeast has a stronger anti-inflammatory effect than the fermented product of a single Thermos thermophilus, and skin keratinocytes are stimulated with an inflammatory effect by 10% of Thermos thermophilus. And the addition of a fermentation product from a combination of yeasts, the secretion of the inflammatory factors IL-1α, IL-6, IL-8 and TNF-α is clearly reduced, corresponding to the anti-inflammatory effect of 100 ppm of dexamethasone, It is milder and the anti-inflammatory effect is clearly superior to 10% of a single Thermos thermophilus fermentation product or a single yeast fermentation.
人体臨床試験の結果によれば、1%のサーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を含有するセラムを、7日間使用した後、経皮水分の流出を低下させるのに対して顕著な効果があり、該サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物は皮膚バリア機能を修復し強化する作用を有することが明らかになった。10%のサーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を含有するセラムを、7日間使用した後、皮膚の黄みを顕著に低下させることができ、該サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物は皮膚色を改善し、黄みを取り除く作用を有することが明らかになった。 According to the results of human clinical trials, serum containing 1% of a fermentation product of the combination of Thermus thermophilus and yeast is remarkable for reducing transdermal water outflow after 7 days of use. It has been shown that the fermentation product of the combination of Thermus thermophilus and yeast has an effect of repairing and enhancing the skin barrier function. Serum containing 10% of the fermented product of Thermus thermophilus and yeast combination can significantly reduce the yellowness of the skin after 7 days of use, resulting in a significant decrease in the yellowness of the skin. The fermentation product was found to have an effect of improving skin color and removing yellowness.
以下、具体的な実施形態によって本発明が如何に実現されるのかを説明するが、これらの説明は本発明の技術的思想を説明するためのものであり、本発明を限定するためのものではない。具体的な保護範囲は特許請求の範囲に準ずる。ただし、実施例2〜6、8〜9は参考例である。 Hereinafter, how the present invention is realized by specific embodiments will be described.However, these descriptions are for explaining the technical idea of the present invention and are not for limiting the present invention. Absent. The specific scope of protection is in accordance with the claims. However, Examples 2 to 6 and 8 to 9 are reference examples.
(実施例1)
〔サーマス・サーモフィラスおよび酵母菌の組合せによる発酵方法(1)〕
材料は以下のとおりである。
<培養液の調製および成分>
20Lの培養液の配合は60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであり、pH値は酸またはアルカリ(塩酸または水酸化ナトリウム溶液)で調整および制御し、水で20Lまで補充し、異なる量の培養液は上記配合に応じて増減する。本発明は、特に指定されない限り、全ての実施例はいずれも上記配合の培地成分を採用して菌培養の培養液とする。当然ながら、実際の工業生産においては、異なる要求に応じて配合することができるが、このような配合成分はいずれも酵母および/またはサーマス・サーモフィラスを培養する一般的な配合成分である。
(Example 1)
[Fermentation method using a combination of Thermos thermophilus and yeast (1)]
The materials are as follows.
<Preparation of culture solution and components>
The formulation of the 20 L culture was 60 g peptone, 4 g wort, 7 g anhydrous magnesium sulfate, 2.4 g potassium dihydrogen phosphate, 40 g ammonium sulfate, 1 g anhydrous iron chloride, 5 g sodium chloride, pH The value is adjusted and controlled with an acid or alkali (hydrochloric acid or sodium hydroxide solution), supplemented with water up to 20 L, and different volumes of the culture solution increase or decrease according to the above formulation. In the present invention, unless otherwise specified, all of the Examples employ a medium component having the above composition to prepare a culture solution for bacterial culture. Naturally, in actual industrial production, they can be blended according to different requirements, but all such blending components are common blending components for culturing yeast and / or Thermos thermophilus.
サッカロマイセス・セレビシエはCICC1596であり、中国工業微生物菌種保存管理センターから購入され、保存番号はCICC1596(商業的な購入により取得)である。 Saccharomyces cerevisiae is CICC1596, purchased from the China Center for the Preservation and Control of Microbial Species, and the storage number is CICC1596 (obtained by commercial purchase).
サーマス・サーモフィラスHB27は、アメリカン・タイプ・カルチャー・コレクション(ATCC)から購入され、保存番号はBAA−163(商業的な購入により取得)である。 Thermus Thermophilus HB27 is purchased from the American Type Culture Collection (ATCC) and has a storage number BAA-163 (obtained by commercial purchase).
1. 菌種拡大培養
(ステップ1)
<1.1 サッカロマイセス・セレビシエの増殖>
(1)クリーンベンチにおいて試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに接種し、200rpm(1分ごとに200回転)、30℃で10hほど培養し、菌体は対数増殖期にある;
(2)対数増殖期にある菌体を2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積百分率、200ミリリットルのステップ(1)の対数増殖期にある酵母培養液)とし、200rpm、30℃で10hほど培養する;
(3)ステップ(2)で培養した3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する;
(4)30Lの菌液を300Lが入った二級種の500Lのタンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する。
1. Expansion of bacterial species (Step 1)
<1.1 Propagation of Saccharomyces cerevisiae>
(1) One loop of Saccharomyces cerevisiae CICC1596 on a test tube slope was taken in a clean bench, inoculated into a 250 ml Erlenmeyer flask containing 50 ml of a culture solution (pH 4.8 ± 0.2), and 200 rpm (every minute). Culturing at 30 ° C. for about 10 h, and the cells are in logarithmic growth phase;
(2) The cells in the logarithmic growth phase are inoculated into a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and the inoculum amount is increased by 10% (volume percentage, 200 ml step (1)). Yeast culture in a logarithmic growth phase), and cultured at 200 rpm and 30 ° C. for about 10 hours;
(3) 3 L of the bacterial species cultured in step (2) is inoculated into a first-class 50 L tank containing 30 L of fermentation broth (pH 4.8 ± 0.2), and the aeration rate is increased to 5 m 3 / h / 50 L. Maintain and incubate at 200 rpm, 30 ° C. for about 10 h;
(4) 30 L of the bacterial solution is transferred to a 500 L tank of a second grade containing 300 L, and the aeration rate is maintained at 5 m 3 / h / 50 L, and the cells are cultured at 200 rpm and 30 ° C. for about 10 hours.
<1.2 サーマス・サーモフィラスの増殖>
クリーンベンチにおいてサーマス・サーモフィラスHB27の凍結溶液を2ml取り、2Lの培養液(pH7.8±0.2)が入った2.5Lの三角フラスコに接種し、通気量を5m3/h/50Lに維持し、150rpm、65℃で12hほど培養し、菌体が対数増殖期になってから、30Lの菌液を300Lの培養液が入った二級種の500Lタンクに接種する。
<1.2 Propagation of Thermos thermophilus>
Take 2 ml of a frozen solution of Thermos thermophilus HB27 in a clean bench, inoculate it into a 2.5 L Erlenmeyer flask containing 2 L of culture solution (pH 7.8 ± 0.2), and adjust the aeration rate to 5 m 3 / h / 50 L. The culture is maintained and cultured at 150 rpm and 65 ° C. for about 12 hours. After the cells have reached the logarithmic growth phase, 30 L of the bacterial solution is inoculated into a 500 L secondary tank containing 300 L of the culture solution.
ここにおける培養液の配合成分は、20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであり、pH値は酸またはアルカリで調整し制御され、水で20Lまで補充する。異なる量の培養液は、上記配合に応じて増減する。 The components of the culture solution were as follows: a mixture of 20 L of the culture solution was 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, and 1 g of anhydrous iron chloride. 5 g of sodium chloride, pH value is adjusted and controlled with acid or alkali, and replenished to 20 L with water. Different amounts of culture will increase or decrease depending on the formulation.
2. (ステップ2)
<一次発酵>
300Lの二級種タンク内の(ステップ(4)の後の)酵母菌培養液を2400Lの培養液(pH4.8±0.2)が入った5000Lの発酵タンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で14hほど培養する。
2. (Step 2)
<Primary fermentation>
The yeast culture (after step (4)) in the 300 L secondary seed tank was transferred to a 5000 L fermentation tank containing 2400 L culture (pH 4.8 ± 0.2) and the aeration was 5 m 3. / H / 50L, and culture at 200 rpm and 30 ° C for about 14 hours.
この際の培養液の配合成分は、20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであり、pH値は酸またはアルカリで調整し制御され、水で20Lまで補充する。異なる量の培養液は、上記配合に応じて増減する。 At this time, the components of the culture solution were as follows: 20 L of the culture solution was 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, and 1 g of anhydrous chloride. Iron, 5 g sodium chloride, pH value adjusted and controlled with acid or alkali, replenish up to 20 L with water. Different amounts of culture will increase or decrease depending on the formulation.
3. (ステップ3)
<二次発酵>
一次発酵(ステップ2)培養液の温度を30℃から65℃に昇温させた後、温度が65℃達した後、すぐ300Lのサーマス・サーモフィラス増殖液をこの発酵タンクに移し、通気量を5m3/h/50Lに維持し、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養する。
3. (Step 3)
<Secondary fermentation>
Primary fermentation (step 2) After the temperature of the culture solution was raised from 30 ° C. to 65 ° C., and the temperature reached 65 ° C., 300 L of the Thermos thermophilus growth solution was immediately transferred to this fermentation tank, and the aeration rate was 5 m. The mixture is maintained at 3 / h / 50 L, stirred at 150 rpm, adjusted to a pH value of 7.8 ± 0.2 with an alkaline solution, and cultured at 150 rpm at 65 ° C. for about 18 hours.
この際の培養液の配合成分は、20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであり、pH値は酸またはアルカリで調整し制御され、水で20Lまで補充する。異なる量の培養液は、上記配合に応じて増減する。 At this time, the components of the culture solution were as follows: 20 L of the culture solution was 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, and 1 g of anhydrous chloride. Iron, 5 g sodium chloride, pH value adjusted and controlled with acid or alkali, replenish up to 20 L with water. Different amounts of culture will increase or decrease depending on the formulation.
4. 分離精製
<遠心による除菌>
ステップ3の二次発酵を経た培養液に対し、プレートフレーム濾過を経て、菌体を濾過膜(0.22um)にブロックし、発酵上清を得る。
4. Separation and purification <Eradication by centrifugation>
The culture solution that has undergone the secondary fermentation in step 3 is filtered through a plate frame to block the cells on a filter membrane (0.22 μm), thereby obtaining a fermentation supernatant.
<浄化>
発酵上清を活性炭に加え不純物を吸着させ、悪臭を除去し、複数層の脱脂ガーゼおよび珪藻土を利用しシンダを濾過する(活性炭の添加比率は6%であり、活性炭は環宇炭業から購入)。
<Purification>
The fermentation supernatant is added to activated carbon to absorb impurities, remove odors, and filter synda using multiple layers of defatted gauze and diatomaceous earth (addition ratio of activated carbon is 6%, activated carbon is purchased from Kantan Co., Ltd.) .
<濾過>
浄化された発酵液を0.22umの濾過膜によって濾過し、サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を得る。
<Filtration>
The clarified fermentation liquor is filtered through a 0.22 um filtration membrane to obtain a fermentation product from a combination of Thermos thermophilus and yeast.
(実施例2)
〔単独で酵母発酵する方法〕
単独で酵母発酵することによる生成物の具体的な実施形態は以下のとおりである。
(Example 2)
[Method of fermenting yeast alone]
Specific embodiments of the product of yeast fermentation alone are as follows.
<培養液の調製>
20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであるものについて、pH値を酸またはアルカリで調整および制御し、水を20Lまで補充し、異なる量の培養液は、上記配合に応じて増減する。
<Preparation of culture solution>
About 20 L of culture solution containing 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, 1 g of anhydrous iron chloride, and 5 g of sodium chloride The pH value is adjusted and controlled with an acid or alkali, water is replenished up to 20 L, and different amounts of culture are increased or decreased according to the above formulation.
1. 菌種拡大培養
(1)クリーンベンチににおいて試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに接種し、200rpm(1分ごとに200回転)、30℃で10hほど培養し、菌体は対数増殖期にある;
(2)対数増殖期にある菌体を2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積百分率、200ミリリットルのステップ(1)の対数増殖期にある酵母培養液)とし、200rpm、30℃で10hほど培養する;
(3)ステップ(2)で培養した3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する;
(4)30Lの菌液を300Lが入った二級種の500Lのタンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する。
1. Bacterial strain expansion culture (1) One loop of Saccharomyces cerevisiae CICC1596 on a test tube slope was taken on a clean bench and inoculated into a 250 ml Erlenmeyer flask containing 50 ml of culture solution (pH 4.8 ± 0.2). Cultivation at 200 rpm (200 rotations per minute) at 30 ° C. for about 10 h, and the cells are in logarithmic growth phase;
(2) The cells in the logarithmic growth phase are inoculated into a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and the inoculum amount is increased by 10% (volume percentage, 200 ml step (1)). Yeast culture in a logarithmic growth phase), and cultured at 200 rpm and 30 ° C. for about 10 hours;
(3) 3 L of the bacterial species cultured in step (2) is inoculated into a first-class 50 L tank containing 30 L of fermentation broth (pH 4.8 ± 0.2), and the aeration rate is increased to 5 m 3 / h / 50 L. Maintain and incubate at 200 rpm, 30 ° C. for about 10 h;
(4) 30 L of the bacterial solution is transferred to a 500 L tank of a second grade containing 300 L, and the aeration rate is maintained at 5 m 3 / h / 50 L, and the cells are cultured at 200 rpm and 30 ° C. for about 10 hours.
2. 発酵
300Lの二級種タンク内の酵母菌培養液を2700Lの培養液(pH4.8±0.2)が入った5000Lの発酵タンクに移し、通気量を5m3/h/50Lに維持し、200rpm、30℃で14hほど培養する。
2. Fermentation The yeast culture in the 300 L secondary seed tank was transferred to a 5000 L fermentation tank containing 2700 L culture (pH 4.8 ± 0.2), and the aeration was maintained at 5 m 3 / h / 50 L. Then, the cells are cultured at 200 rpm and 30 ° C. for about 14 hours.
<培養液の調製>
20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであるものについて、pH値は酸またはアルカリで調整および制御し、水を20L補充し、異なる量の培養液は、上記配合に応じて増減する。
<Preparation of culture solution>
About 20 L of culture solution containing 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, 1 g of anhydrous iron chloride, and 5 g of sodium chloride The pH value is adjusted and controlled with an acid or alkali, supplemented with 20 L of water, and different amounts of the culture solution increase or decrease according to the above composition.
3. 分離精製
<遠心による除菌>
ステップ2の発酵を経た培養液に対し、プレートフレーム濾過を経て、菌体を濾過膜(0.22um)にブロックし、発酵上清を得る。
3. Separation and purification <Eradication by centrifugation>
With respect to the culture solution that has undergone the fermentation in Step 2, the bacterial cells are blocked by a filtration membrane (0.22 μm) through plate frame filtration to obtain a fermentation supernatant.
<浄化>
発酵上清を活性炭に加え不純物を吸着させ、悪臭を除去し、複数層の脱脂ガーゼおよび珪藻土を利用してシンダを濾過する(活性炭の添加比率は6%であり、活性炭は環宇炭業から購入)。
<Purification>
The fermentation supernatant is added to activated carbon to absorb impurities, remove odors, and filter synda using multiple layers of defatted gauze and diatomaceous earth (addition ratio of activated carbon is 6%, activated carbon is purchased from Kantan Co., Ltd.) ).
<濾過>
浄化した発酵液を0.22umの濾過膜によって濾過し、単一の酵母菌発酵生成物を得る。
<Filtration>
The clarified fermentation liquor is filtered through a 0.22 um filtration membrane to obtain a single yeast fermentation product.
(実施例3)
〔単独で好熱性細菌を発酵させる方法〕
単一のサーマス・サーモフィラス発酵生成物の具体的な実施形態は以下のとおりである。
(Example 3)
(Method of fermenting thermophilic bacteria alone)
Specific embodiments of a single Thermos thermophilus fermentation product are as follows.
<培養液の調製>
20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであるものについて、pH値は酸またはアルカリで調整および制御し、水を20Lまで補充し、異なる量の培養液は、上記配合に応じて増減する。
<Preparation of culture solution>
About 20 L of culture solution containing 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, 1 g of anhydrous iron chloride, and 5 g of sodium chloride , PH value is adjusted and controlled with acid or alkali, water is replenished up to 20L, and different amounts of culture solution increase or decrease according to the above formula.
1. 菌種拡大培養
クリーンベンチにおいてサーマス・サーモフィラスHB27の凍結溶液を2ml取り、2Lの培養液(pH7.8±0.2)が入った2.5Lの三角フラスコに接種し、通気量を5m3/h/50Lに維持し、150rpm、65℃で12hほど培養し、菌体が対数増殖期になってから、30Lの菌液を300Lの培養液が入った二級種の500Lタンクに接種する。
1. Bacterial species expansion culture Take 2 ml of a frozen solution of Thermos thermophilus HB27 in a clean bench, inoculate it into a 2.5 L Erlenmeyer flask containing 2 L of a culture solution (pH 7.8 ± 0.2), and inhale a volume of 5 m. 3 / h / 50L, culture at 150 rpm, 65 ° C for about 12h, and after the cells reached the logarithmic growth phase, inoculate 30L of bacterial solution into a 500L secondary-grade tank containing 300L of culture solution I do.
2. 発酵
300Lのサーマス・サーモフィラスの増殖液を2700Lの培養液を含有する発酵タンクに移し、通気量を5m3/h/50Lに維持し、150rpmで撹拌し、pH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養する。
2. Fermentation Transfer 300 L of the growth solution of Thermus thermophilus to a fermentation tank containing 2700 L of culture, maintain the aeration at 5 m 3 / h / 50 L, stir at 150 rpm, and adjust the pH to 7.8 ± 0. 2. Incubate at 150 rpm at 65 ° C for about 18 hours.
3. 分離精製
<遠心による除菌>
ステップ2の発酵を経た培養液に対し、プレートフレーム濾過を経て、菌体を濾過膜(0.22um)にブロックし、発酵上清を得る。
3. Separation and purification <Eradication by centrifugation>
With respect to the culture solution that has undergone the fermentation in Step 2, the bacterial cells are blocked by a filtration membrane (0.22 μm) through plate frame filtration to obtain a fermentation supernatant.
<浄化>
発酵上清を活性炭に加え不純物を吸着させ、悪臭を除去し、複数層の脱脂ガーゼおよび珪藻土を利用してシンダを濾過する(活性炭の添加比率は6%であり、活性炭は環宇炭業から購入)。
<Purification>
The fermentation supernatant is added to activated carbon to absorb impurities, remove odors, and filter synda using multiple layers of defatted gauze and diatomaceous earth (addition ratio of activated carbon is 6%, activated carbon is purchased from Kantan Co., Ltd.) ).
<濾過>
浄化した発酵液は0.22umの濾過膜によって濾過し、単一のサーマス・サーモフィラス発酵生成物を得る。
<Filtration>
The clarified fermentation liquor is filtered through a 0.22 um filtration membrane to obtain a single Thermos thermophilus fermentation product.
(実施例4)
〔実施例2および3の発酵生成物を混合して得られた試薬〕
実施例2および3の発酵生成物を取り、重量比1:1で混合して複合試薬を得る。
(Example 4)
[Reagents obtained by mixing the fermentation products of Examples 2 and 3]
The fermentation products of Examples 2 and 3 are taken and mixed in a 1: 1 weight ratio to obtain a complex reagent.
(実施例5)
〔酵母および好熱性細菌の共培養方法(2)〕
サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物の具体的な実施形態は以下のとおりである。
(Example 5)
[Method of co-culturing yeast and thermophilic bacteria (2)]
A specific embodiment of a fermentation product with a combination of Thermus thermophilus and yeast is as follows.
<培養液の調製>
20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであるものについて、pH値は酸またはアルカリで調整および制御し、水を20Lまで補充し、異なる量の培養液は、上記配合に応じて増減する。
<Preparation of culture solution>
About 20 L of culture solution containing 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, 1 g of anhydrous iron chloride, and 5 g of sodium chloride , PH value is adjusted and controlled with acid or alkali, water is replenished up to 20L, and different amounts of culture solution increase or decrease according to the above formula.
1. 菌種拡大培養
<酵母菌の増殖>
クリーンベンチにおいて試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに接種し、200rpm、30℃で10hほど培養し、菌体は対数増殖期にある。2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積比、ここで、対数増殖期にある200ミリリットルの酵母培養液を接種する)とし、200rpm、30℃で10hほど培養する。3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持し、200rpm、30℃で10hほど培養する。30Lの菌液を300Lの培養液が入った二級種の500Lタンクに移す。通気量を5m3/h/50Lに維持させ、200rpm、30℃で10hほど培養する。
1. Bacterial species expansion culture <Propagation of yeast>
One loop of Saccharomyces cerevisiae CICC1596 on a test tube slope was taken in a clean bench, inoculated into a 250 ml Erlenmeyer flask containing 50 ml of a culture solution (pH 4.8 ± 0.2), and cultured at 200 rpm at 30 ° C. for 10 hours. The cells are in a logarithmic growth phase. Inoculate a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and inoculate 10% (by volume, here, inoculating 200 ml of yeast culture in logarithmic growth phase). And culturing at 200 rpm and 30 ° C. for about 10 hours. 3L of the bacterial species is inoculated into a first-class 50L tank containing a 30L fermentation broth (pH 4.8 ± 0.2), the aeration rate is maintained at 5m 3 / h / 50L, and about 10 hours at 200 rpm and 30 ° C. Incubate. Transfer 30 L of bacterial solution to a second-class 500 L tank containing 300 L of culture solution. The aeration rate is maintained at 5 m 3 / h / 50 L, and the cells are cultured at 200 rpm and 30 ° C. for about 10 hours.
<サーマス・サーモフィラスの増殖>
クリーンベンチにおいてサーマス・サーモフィラスHB27の凍結溶液を2ml取り、2Lの培養液(pH7.8±0.2)が入った2.5Lの三角フラスコに接種し、通気量を5m3/h/50Lに維持させ、150rpm、65℃で12hほど培養し、菌体が対数増殖期になってから、30Lの菌液を300Lの培養液が入った二級種の500Lタンクに接種して培養し、通気量を5m3/h/50Lに維持させ、150rpm、65℃で12hほど培養する。
<Propagation of Thermos thermophilus>
Take 2 ml of a frozen solution of Thermos thermophilus HB27 in a clean bench, inoculate it into a 2.5 L Erlenmeyer flask containing 2 L of culture solution (pH 7.8 ± 0.2), and adjust the aeration rate to 5 m 3 / h / 50 L. The cells were maintained at 150 rpm and cultured at 65 ° C. for about 12 hours. After the cells reached the logarithmic growth phase, 30 L of the bacterial liquid was inoculated into a 500 L secondary-grade tank containing 300 L of culture liquid, and cultured. The volume is maintained at 5 m 3 / h / 50 L, and the cells are cultured at 150 rpm at 65 ° C. for about 12 hours.
2. 発酵
300Lの二級種タンク内の酵母菌および300Lの二級種タンク内のサーマス・サーモフィラス培養液を2400Lの培養液(pH4.8±0.2)が入った5000Lの発酵タンクに移し、通気量を5m3/h/50Lに維持させ、200rpm、30℃で14hほど培養する。さらに、発酵液の温度を65℃まで昇温させ、通気量を5m3/h/50Lに維持させ、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、65℃で18hほど培養する。
2. Fermentation The yeast in the 300 L secondary seed tank and the Thermus thermophilus culture in the 300 L secondary seed tank were transferred to a 5000 L fermentation tank containing 2400 L culture (pH 4.8 ± 0.2). The culture is continued at 200 rpm and 30 ° C. for about 14 h while maintaining the aeration rate at 5 m 3 / h / 50 L. Further, the temperature of the fermentation liquor was raised to 65 ° C., the aeration rate was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, and the pH value was adjusted to 7.8 ± 0.2 with an alkaline liquid. Incubate at 18 ° C for about 18 hours.
3. 分離精製
<遠心による除菌>
ステップ2の発酵を経た培養液に対し、プレートフレーム濾過を経て、菌体を濾過膜(0.22um)にブロックし、発酵上清を得る。
3. Separation and purification <Eradication by centrifugation>
With respect to the culture solution that has undergone the fermentation in Step 2, the bacterial cells are blocked by a filtration membrane (0.22 μm) through plate frame filtration to obtain a fermentation supernatant.
<浄化>
発酵上清を活性炭に加え不純物を吸着させ、悪臭を除去し、さらに複数層の脱脂ガーゼおよび珪藻土を利用してシンダを濾過する(活性炭の添加比率は6%であり、活性炭は環宇炭業から購入)。
<Purification>
The fermentation supernatant is added to activated carbon to adsorb impurities, remove odors, and filter synda using multiple layers of defatted gauze and diatomaceous earth. (The activated carbon addition ratio is 6%. Purchase).
<濾過>
浄化した発酵液を0.22umの濾過膜によって濾過し、サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を得る。
<Filtration>
The clarified fermentation liquor is filtered through a 0.22 um filtration membrane to obtain a fermentation product of the combination of Thermos thermophilus and yeast.
(実施例6)
〔酵母および好熱性細菌の共培養方法(3)〕
サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物の具体的な実施形態は以下のとおりである。
(Example 6)
[Coculture method of yeast and thermophilic bacteria (3)]
A specific embodiment of a fermentation product with a combination of Thermus thermophilus and yeast is as follows.
<培養液の調製>
20Lの培養液の配合が60gのペプトン、4gの麦芽汁、7gの無水硫酸マグネシウム、2.4gのリン酸二水素カリウム、40gの硫酸アンモニウム、1gの無水塩化鉄、5gの塩化ナトリウムであるものについて、pH値は酸またはアルカリで調整および制御し、水を20Lまで補充し、異なる量の培養液は、上記配合に応じて増減する。
<Preparation of culture solution>
About 20 L of culture solution containing 60 g of peptone, 4 g of wort, 7 g of anhydrous magnesium sulfate, 2.4 g of potassium dihydrogen phosphate, 40 g of ammonium sulfate, 1 g of anhydrous iron chloride, and 5 g of sodium chloride , PH value is adjusted and controlled with acid or alkali, water is replenished up to 20L, and different amounts of culture solution increase or decrease according to the above formula.
1. 菌種拡大培養
<酵母菌の増殖>
クリーンベンチにおいて試験管斜面上のサッカロマイセス・セレビシエCICC1596を1ループ取り、50mlの培養液(pH4.8±0.2)が入った250mlの三角フラスコに接種し、200rpm、30℃で10hほど培養し、菌体は対数増殖期にあり、2L(pH4.8±0.2)が入った2.5Lの三角フラスコに接種し、接種量を10%(体積比)であり、200rpm、30℃で10hほど培養し、3Lの菌種を30Lの発酵液(pH4.8±0.2)が入った一級種の50Lタンクに接種し、通気量を5m3/h/50Lに維持させ、200rpm、30℃で10hほど培養する。30Lの菌液を300Lが入った二級種の500Lタンクに移し、通気量を5m3/h/50Lに維持させ、200rpm、30℃で10hほど培養する。
1. Bacterial species expansion culture <Propagation of yeast>
One loop of Saccharomyces cerevisiae CICC1596 on a test tube slope was taken in a clean bench, inoculated into a 250 ml Erlenmeyer flask containing 50 ml of a culture solution (pH 4.8 ± 0.2), and cultured at 200 rpm at 30 ° C. for 10 hours. The cells are in a logarithmic growth phase, inoculated into a 2.5 L Erlenmeyer flask containing 2 L (pH 4.8 ± 0.2), and the inoculum is 10% (by volume) at 200 rpm and 30 ° C. After culturing for about 10 hours, 3 L of the bacterial species was inoculated into a 50 L tank of a first-class species containing a 30 L fermentation broth (pH 4.8 ± 0.2), the aeration was maintained at 5 m 3 / h / 50 L, and 200 rpm, Incubate at 30 ° C for about 10 hours. 30 L of the bacterial solution is transferred to a second-class 500 L tank containing 300 L, the aeration is maintained at 5 m 3 / h / 50 L, and the culture is performed at 200 rpm and 30 ° C. for about 10 h.
<サーマス・サーモフィラスの増殖>
クリーンベンチにおいてサーマス・サーモフィラスHB27の凍結溶液を2ml取り、2Lの培養液(pH7.8±0.2)が入った2.5Lの三角フラスコに接種し、通気量を5m3/h/50Lに維持させ、150rpm、65℃で12hほど培養し、菌体が対数増殖期になってから、30Lの菌液を300Lの培養液が入った二級種の500Lタンクに接種する。さらに、発酵液の温度を65℃に昇温させ、通気量を5m3/h/50Lに維持し、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養する。
<Propagation of Thermos thermophilus>
Take 2 ml of a frozen solution of Thermos thermophilus HB27 in a clean bench, inoculate it into a 2.5 L Erlenmeyer flask containing 2 L of culture solution (pH 7.8 ± 0.2), and adjust the aeration rate to 5 m 3 / h / 50 L. The cells are maintained at 150 rpm and cultured at 65 ° C. for about 12 hours. After the cells have reached the logarithmic growth phase, 30 L of the bacterial solution is inoculated into a 500 L tank of a secondary species containing 300 L of the culture solution. Furthermore, the temperature of the fermentation liquor was raised to 65 ° C., the aeration rate was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, and the pH value was adjusted to 7.8 ± 0.2 with an alkaline solution. And cultured at 65 ° C. for about 18 h.
2. 発酵
300Lの二級種タンク内の酵母菌および300Lの二級種タンク内のサーマス・サーモフィラス培養液を同時に2400Lの培養液(pH7.8±0.2)が入った5000Lの発酵タンクに移し、通気量を5m3/h/50Lに維持させ、150rpm、65℃で18hほど培養する。発酵液の温度を30℃に低下させ、通気量を5m3/h/50Lに維持し、200rpmで撹拌し、酸液でpH値を4.8±0.2に調整し、200rpm、30℃で14hほど培養する。
2. Fermentation The yeast in the 300L secondary seed tank and the Thermus thermophilus culture in the 300L secondary seed tank were simultaneously transferred to a 5000L fermentation tank containing 2400L culture (pH 7.8 ± 0.2), The aeration rate is maintained at 5 m 3 / h / 50 L, and the cells are cultured at 150 rpm at 65 ° C. for about 18 hours. The temperature of the fermentation liquor was lowered to 30 ° C., the aeration rate was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 200 rpm, the pH value was adjusted to 4.8 ± 0.2 with an acid solution, and the rotation was performed at 200 rpm and 30 ° C. For about 14 h.
3. 分離精製
<遠心による除菌>
ステップ2の二次発酵を経た培養液に対し、プレートフレーム濾過を経て、菌体を濾過膜(0.22um)にブロックし、発酵上清を得る。
3. Separation and purification <Eradication by centrifugation>
The culture solution that has undergone the secondary fermentation in step 2 is filtered through a plate frame to block the cells on a filter membrane (0.22 μm) to obtain a fermentation supernatant.
<浄化>
発酵上清を活性炭に加え不純物を吸着させ、悪臭を除去し、さらに複数層の脱脂ガーゼおよび珪藻土を利用してシンダを濾過する(活性炭の添加比率は6%であり、活性炭は環宇炭業から購入)。
<Purification>
The fermentation supernatant is added to activated carbon to adsorb impurities, remove odors, and filter synda using multiple layers of defatted gauze and diatomaceous earth. (The activated carbon addition ratio is 6%. Purchase).
<濾過>
浄化した発酵液を0.22umの濾過膜によって濾過し、サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物を得る。
<Filtration>
The clarified fermentation liquor is filtered through a 0.22 um filtration membrane to obtain a fermentation product of the combination of Thermos thermophilus and yeast.
(実施例7)
〔サーマス・サーモフィラスおよび酵母菌の組合せによる発酵方法(4)〕
実施例1との相違点は、二次発酵において、一次発酵(ステップ2)の培養液の温度を30℃から65℃に昇温させた後、65℃に達してから1日後に、300Lのサーマス・サーモフィラス増殖液をこの発酵タンクに移し、通気量を5m3/h/50Lに維持させ、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養することにある。
(Example 7)
[Fermentation method by combination of Thermos thermophilus and yeast (4)]
The difference from Example 1 is that, in the secondary fermentation, after the temperature of the culture solution of the primary fermentation (step 2) was raised from 30 ° C. to 65 ° C., one day after reaching 65 ° C., 300 L The Thermus thermophilus growth solution was transferred to this fermentation tank, the aeration was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, the pH value was adjusted to 7.8 ± 0.2 with an alkaline solution, and 150 rpm, 65 About 18 hours of culturing at ℃.
(実施例8)
〔サーマス・サーモフィラスおよび酵母菌の組合せによる発酵方法(5)〕
実施例1との相違点は、二次発酵において、一次発酵(ステップ2)の培養液の温度を30℃から65℃に昇温させた後、65℃に達してから2日後に、300Lのサーマス・サーモフィラス増殖液をこの発酵タンクに移し、通気量を5m3/h/50Lに維持させ、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養することにある。
(Example 8)
[Fermentation method using a combination of Thermos thermophilus and yeast (5)]
The difference from Example 1 is that, in the secondary fermentation, after the temperature of the culture solution of the primary fermentation (step 2) was raised from 30 ° C. to 65 ° C., two days after reaching 65 ° C., 300 L The Thermus thermophilus growth solution was transferred to this fermentation tank, the aeration was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, the pH value was adjusted to 7.8 ± 0.2 with an alkaline solution, and 150 rpm, 65 About 18 hours of culturing at ℃.
(実施例9)
〔サーマス・サーモフィラスおよび酵母菌の組合せによる発酵方法(6)〕
実施例1との相違点は、二次発酵において、一次発酵(ステップ2)の培養液の温度を30℃から75℃に昇温させた後、75℃に達してから3日後に、300Lのサーマス・サーモフィラス増殖液をこの発酵タンクに移し、通気量を5m3/h/50Lに維持させ、150rpmで撹拌し、アルカリ液でpH値を7.8±0.2に調整し、150rpm、65℃で18hほど培養することにある。
(Example 9)
[Fermentation method (6) using a combination of Thermos thermophilus and yeast]
The difference from Example 1 is that, in the secondary fermentation, after the temperature of the culture solution of the primary fermentation (step 2) was raised from 30 ° C. to 75 ° C., and three days after reaching 75 ° C., 300 L The Thermus thermophilus growth solution was transferred to this fermentation tank, the aeration was maintained at 5 m 3 / h / 50 L, the mixture was stirred at 150 rpm, the pH value was adjusted to 7.8 ± 0.2 with an alkaline solution, and 150 rpm, 65 About 18 hours of culturing at ℃.
(実施例10)
<細胞毒性試験>
対数期細胞(ヒト皮膚線維芽細胞およびヒト皮膚角質細胞)を収集し、培養液で単一の細胞懸濁液を製造し、最終的な細胞濃度を40000cell/mLに調整し、96ウェルプレートに100uLの細胞懸濁液を加え、5%CO2、37℃で孵化し、細胞が壁に接着した後、試験物質を加え(実施例1〜9の各発酵生成物を含む細胞培養液)、80%〜90%に培養し融合させた後、各ウェルにMTT溶液20uLを加え3h孵化し続け、培養を終了する。慎重にウェル内の培地を吸い取り、各ウェルに100uLのDMSOを加え、10min振動することにより、結晶物を十分に融解させる。マイクロプレートリーダで各ウェルの吸光度の値を測定し、490nmの波長を選択し、630nmを参照波長とする。各処理を5回繰り返す。
(Example 10)
<Cytotoxicity test>
Log phase cells (human dermal fibroblasts and human keratinocytes) were collected, a single cell suspension was prepared in culture, the final cell concentration was adjusted to 40000 cells / mL, and the cells were added to a 96-well plate. After adding 100 uL of the cell suspension, incubating at 37 ° C., 5% CO 2 and attaching the cells to the wall, a test substance was added (cell culture solution containing each fermentation product of Examples 1 to 9). After culturing and fusing to 80% to 90%, 20 uL of MTT solution is added to each well, hatching is continued for 3 h, and the culture is terminated. Carefully aspirate the medium in the wells, add 100 uL DMSO to each well, and shake for 10 min to allow the crystals to thaw sufficiently. The absorbance value of each well is measured with a microplate reader, a wavelength of 490 nm is selected, and 630 nm is set as a reference wavelength. Each process is repeated five times.
実施例1〜9の各発酵生成物を含む高糖質のDMEM細胞培養液を加え、細胞培養液は3%の発酵生成物を含む高糖質のDMEM細胞培養液であり、3%の実施例1(サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物)のヒト皮膚線維芽細胞の成長率は131%であり、3%の実施例3(単一のサーマス・サーモフィラス発酵生成物)に比べて20%向上されており、具体的には以下の表1を参照する。 A high saccharide DMEM cell culture containing each fermentation product of Examples 1-9 was added, and the cell culture was a high saccharide DMEM cell culture containing 3% fermentation product and 3% The growth rate of human dermal fibroblasts of Example 1 (a fermentation product of the combination of Thermos thermophilus and yeast) is 131%, compared to 3% of Example 3 (a single Thermos thermophilus fermentation product). For example, see Table 1 below.
10%の実施例1(サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物)が添加されたヒト皮膚角質細胞の成長率は101%であり、100ppmのデキサメタゾンが添加されたヒト皮膚角質細胞の成長率は89%である。10%の実施例1(サーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物)は100ppmのデキサメタゾンに比べてさらに穏やかである。結果は以下の表1のとおりである。 The growth rate of human skin keratinocytes supplemented with 10% of Example 1 (fermentation product of the combination of Thermus thermophilus and yeast) is 101%, and the growth of human skin keratinocytes supplemented with 100 ppm of dexamethasone The rate is 89%. 10% of Example 1 (the fermentation product of the combination of Thermus thermophilus and yeast) is even milder than 100 ppm dexamethasone. The results are as shown in Table 1 below.
分散分析によれば、実施例1および7と実施例2〜6および8〜9との差はそれぞれP<0.01であり、極めて顕著な差に達し、実施例2〜6および8〜9の間は顕著な差がない。これは、本発明の実施例1の組合せによる培養方法は、ヒト皮膚線維芽細胞の成長率を顕著に促進することができ、ヒト皮膚角質細胞に対しても顕著な促進作用があり、混合培養の効果が最もよく、実施例1または実施例7の混合作用の効果が最もよいことを説明する。同時に、混合培養を行う際、混合するタイミングも非常に重要であり、温度が昇温した後すぐに混合しまたは1日後に混合すると、効果が最もよいが、2日超えて混合する効果は繊維芽細胞に対する効果が急激に低下することも説明する。類似する効果は細胞のヒト皮膚角質細胞の成長率に対する影響と類似している。 According to analysis of variance, the difference between Examples 1 and 7 and Examples 2-6 and 8-9 was P <0.01, respectively, and reached a very significant difference, and Examples 2-6 and 8-9 There is no noticeable difference between the two. This is because the culture method according to the combination of Example 1 of the present invention can remarkably promote the growth rate of human dermal fibroblasts, and also has a remarkable promoting effect on human keratinocytes. It is explained that the effect of (1) is the best, and the effect of the mixing action of the embodiment 1 or 7 is the best. At the same time, when performing mixed culture, the timing of mixing is also very important. Mixing immediately after the temperature is raised or mixing one day later is the best, but the effect of mixing beyond 2 days is the fiber. It also explains that the effect on blasts declines sharply. Similar effects are similar to the effects of cells on the growth rate of human cutaneous keratinocytes.
(実施例11)
<消炎効果試験>
対数期のヒト皮膚角質細胞を収集し、培養液で単一の細胞懸濁液を製造し、最終的な細胞濃度を40000cell/mLに調整し、96ウェルプレートに100uLの細胞懸濁液を加え、5%CO2、37℃で24時間孵化し、培養液を吸出し、PBSで1回洗い、吸出し、さらに20uLのPBSを加え、UVBを照射し、輻射量を60 mJ/cm2に制御し、試験物質に入れ替え(実施例1〜9の各発酵生成物を、高糖質のDMEM細胞培養液で希釈し、濃度が10%である各発酵生成物)、24h培養した後、培養液の上清を収集する。炎症因子(IL−1a、IL−6、IL−8、TNF−a)の含有量(完成品試薬キットの説明書に従って検出する)を検出する。試験を5回繰り返す。
(Example 11)
<Anti-inflammatory effect test>
Harvest logarithmic phase of human keratinocytes, make single cell suspension in culture, adjust final cell concentration to 40000 cells / mL, add 100 uL cell suspension to 96 well plate Hatch at 37 ° C., 5% CO 2 for 24 hours, aspirate the culture solution, wash once with PBS, aspirate, add 20 uL of PBS, irradiate with UVB, and control the radiation amount to 60 mJ / cm 2. The test substance was replaced (each fermentation product of Examples 1 to 9 was diluted with a high-sugar DMEM cell culture solution and each fermentation product having a concentration of 10%), and cultured for 24 hours. Collect the supernatant. The content of inflammatory factors (IL-1a, IL-6, IL-8, TNF-a) is detected (detected according to the instructions of the finished reagent kit). Repeat the test 5 times.
結果によると、10%のサーマス・サーモフィラスおよび酵母菌の組合せによる発酵生成物(実施例1)を含む高糖質のDMEM細胞培養液を加える場合、炎症因子の含有量IL−1αは110.12pg/mLであり、IL−6は16.23pg/mLであり、IL−8は1300.20pg/mLおよびTNF−αは42.25pg/mLであり、分泌量は10%の単一のサーマス・サーモフィラス発酵生成物に比べて明らかに減少され、消炎効果が明らかであり(分析をよると、炎症因子の含有量が顕著に低下されている)、100ppmのデキサメタゾンの消炎効果に相当する。 The results show that when adding a high-sugar DMEM cell culture containing 10% of the fermentation product of the combination of Thermus thermophilus and yeast (Example 1), the content of inflammatory factor IL-1α is 110.12 pg / IL, IL-6 is 16.23 pg / mL, IL-8 is 1300.20 pg / mL and TNF-α is 42.25 pg / mL, and the secreted amount is 10% of a single thermus. The anti-inflammatory effect is clearly reduced compared to the Thermophilus fermentation product, and the anti-inflammatory effect is evident (analysis shows a significant reduction in the content of inflammatory factors), corresponding to the anti-inflammatory effect of 100 ppm dexamethasone.
これは、本発明の培養方法により得られた活性生成物は炎症因子の生成を顕著に低下させることができ、単一の発酵または発酵の混合物に比べて、分散分析によると、実施例1、7とその他の処理とはいずれも高い有意差(具体的な試験データは省略する)に達していることを説明する。これは、酵母およびサーマス・サーモフィラスの共培養は、酵母を採用して一次培養し、その後二次混合培養を行うことにより、2種類の菌の生理活性物質に対していずれも促進作用を果たし、活性も顕著に向上されていることを説明する。逆に、単独培養することや単独培養後混合すること、およびその他の方式で混合培養することは、このような効果を得ることができない。これは、サーマス・サーモフィラスにビタミンB群が含有されていることに起因すると考えられるが、ビタミンB群の主要作用はおそらく皮膚の消炎であり、これは、2種類の異なる菌を共培養した後、サーマス・サーモフィラス内のビタミンB群の活性を向上させることができ、またはその他の不明な物質によりビタミンB群により大きな活性を持たせることを説明することができる。 This is because the active product obtained by the cultivation method of the present invention can significantly reduce the production of inflammatory factor, and according to the analysis of variance according to Example 1, compared to a single fermentation or a mixture of fermentations, It will be explained that all of 7 and other processes have reached a high significant difference (specific test data is omitted). This is because the co-culture of yeast and Thermus thermophilus is a primary culture using yeast, and then a secondary mixed culture is performed, both of which act on the bioactive substances of the two types of bacteria, Explain that the activity is also significantly improved. Conversely, single culture, mixing after single culture, and mixed culture by other methods cannot obtain such an effect. This is thought to be due to the inclusion of the B vitamins in Thermus thermophilus, but the main effect of the B vitamins is probably skin inflammation, which occurs after co-culturing two different bacteria. Can explain the increased activity of the B vitamins in Thermus thermophilus, or explain that other unknown substances make the B vitamins more active.
また、本発明は、9つの処理におけるビタミンB群に対して同時に通常の方法で測定した結果、各処理における100グラムごとの発酵生成物のビタミンB群は明らかな変化がないことを発見した。これは、組合せによる発酵は一部のビタミンB群にさらなる活性を有する因子を生成させることによって、ビタミンB群の活性を向上させ、さらに優れた消炎作用を有することを説明している。これらの具体的な活性因子の生成メカニズムは、さらに検討する必要がある。 The present invention also found that there was no apparent change in the vitamin B group of the fermented product per 100 grams in each treatment as a result of simultaneously measuring the vitamin B groups in the nine treatments by the usual method. This explains that fermentation by the combination increases the activity of the vitamin B group by producing a factor having further activity in some vitamin B groups, and has an excellent anti-inflammatory effect. The mechanism of production of these specific activators requires further investigation.
(実施例12)
<皮膚のバリア修復試験>
皮膚角質層は優れたバリア機能を有するが、温度、風、太陽光などの外部要因の影響を受けて損傷するため、適時にバリア修復を行うことは非常に重要である。本試験では、TEWL(Trans epidermal Water Loss、TEWL)を指標として採用し、TEWLが低いほど皮膚のバリア修復能力が高い。ここで、試験機器は、ドイツCK社の皮膚水分流出(TEWL)試験プローブTM300であり、試験条件は、被験者が温度22℃±1℃、湿度50%±5%の室内で20min間静座することである。
(Example 12)
<Skin barrier repair test>
The stratum corneum has an excellent barrier function, but is damaged by the influence of external factors such as temperature, wind and sunlight, so that timely repair of the barrier is very important. In this test, TEWL (Trans epidermal Water Loss, TEWL) is used as an index, and the lower the TEWL, the higher the skin barrier repair ability. Here, the test device is a skin moisture outflow (TEWL) test probe TM300 of CK, Germany. The test condition is that the subject sits in a room at a temperature of 22 ° C. ± 1 ° C. and a humidity of 50% ± 5% for 20 minutes. It is.
<試験方法>
年齢が22〜55歳、無皮膚疾患または過去ある薬物、化粧品または一部の化学物質に対し深刻なアレルギーがあった20名のボランティアを選ぶ。朝晩2回連続して、顔の半分に対照群および10%の実施例1〜9の発酵生成物を含有するセラム(セラムの主要成分には、脱イオン水、Tween−80、プロピレングリコール、防腐剤および10%の本発明の実施例1〜9の発酵生成物があり、10%の発酵生成物に採用された溶媒はPBSを溶媒として調製されており、pHは7.1である)を使用し、製品を7日間ほど使用した後TEWL試験を行い、TEWLの変化率を計算する。TEWLの変化率の計算方式は、 [(7日後のTEWL値−7日前のTEWL値)/7日前のTEWL値]*100%であり、TEWLの変化率が低いほど、皮膚に対するバリア作用がよい(各実施例において5回繰り返す)。結果は表3のとおりである。
<Test method>
Select 20 volunteers, 22-55 years old, who have a skinless disease or have a serious allergy to some past drugs, cosmetics or some chemicals. Two consecutive mornings and evenings, a serum containing the control group and 10% of the fermentation products of Examples 1 to 9 in the half of the face (the main components of serum include deionized water, Tween-80, propylene glycol, preservatives) Agent and 10% of the fermentation products of Examples 1 to 9 of the present invention, the solvent employed for the 10% fermentation product was prepared using PBS as solvent and the pH is 7.1) After using the product for about 7 days, a TEWL test is performed, and the rate of change of the TEWL is calculated. The calculation method of the change rate of TEWL is [(TEWL value after 7 days−TEWL value before 7 days) / TEWL value before 7 days] * 100%. The lower the change rate of TEWL, the better the barrier effect on the skin. (Repeated 5 times in each example). Table 3 shows the results.
有意差異分析によれば、実施例1、7〜8と実施例2〜6、9とはバリアに対する修復効果が高い有意差に達し(具体的な試験データは省略する)、これは、本発明の実施例1の方法によって培養して得られた共培養生成物は皮膚角質層に対して顕著な修復機能を有することができ、皮膚角質層細胞を修復する生理活性物質の活性または産出量、またはその他の補助因子の産出量または活性を向上させた可能性がある。 According to the significant difference analysis, Examples 1 and 7 to 8 and Examples 2 to 6 and 9 reached a significant difference in which the repair effect on the barrier was high (specific test data is omitted). The co-cultured product obtained by culturing according to the method of Example 1 can have a remarkable repair function on the stratum corneum of the skin, and the activity or output of the physiologically active substance for repairing the cells of the stratum corneum of the skin, Or it may have increased the yield or activity of other cofactors.
(実施例13)
<皮膚黄み消去試験>
CIEXYZシステムを利用し、数学的方法によって変換しCIEL*a*b*色空間を得る。該空間は1つの輝度(L)および2つの色相(a、b)軸により構成される。輝度はグレースケールを表示する尺度であり、その値は0〜100の間であり、0は黒を表示し、100は白を表示する。a*は赤から緑の間の彩度であり、その変化範囲は+60〜−60であり、正の値は赤の強さの変化を表示する。b*は黄色から藍の間の彩度を示し、その変化範囲は+60〜−60であり、正の値は黄色の強さの変化を表示する。皮膚の色もL*a*b*で表示し、b*値が低いほど黄み消去の効果が明らかであり、Δb*が低いほど、黄み消去の効果がよい。
(Example 13)
<Skin yellowing elimination test>
Using the CIEXYZ system, conversion is performed by a mathematical method to obtain a CIEL * a * b * color space. The space is constituted by one luminance (L) and two hue (a, b) axes. Luminance is a measure for displaying gray scale, and its value is between 0 and 100, where 0 displays black and 100 displays white. a * is the saturation between red and green, and its change range is +60 to -60, and a positive value indicates a change in the intensity of red. b * indicates the saturation between yellow and indigo, and its change range is +60 to -60, and a positive value indicates a change in yellow intensity. The skin color is also indicated by L * a * b *, and the lower the b * value, the clearer the effect of yellowing elimination, and the lower the Δb *, the better the yellowing effect.
<試験方法>
年齢が22〜55歳であるボランティア20人を選び、朝晩2回連続して、顔の半分に対照群および10%の実施例1〜6の発酵生成物を含有するセラム(セラムの主要成分には、脱イオン水、Tween−80、プロピレングリコール、防腐剤がある)を使用し、連続に7日間使用する(試験を5回繰り返す)。製品を使用する前に、製品を7日間使用した後VISIA撮影を行い、各群の平均Δb*値を計算する。
<Test method>
Twenty volunteers aged 22 to 55 years were selected, and two consecutive mornings and evenings, a serum containing the control group and 10% of the fermentation product of Examples 1 to 6 in half of the face (a major component of serum) Use deionized water, Tween-80, propylene glycol, preservatives) and use for 7 consecutive days (test repeated 5 times). Before using the product, VISIA imaging is performed after using the product for 7 days, and the average Δb * value of each group is calculated.
ここで、試験機器は、LAB試験機器のspectrophotometer CM2600d(Minolta、Osaka、日本)であり、試験前に被験者は顔を徹底的に洗顔した後ティッシュで拭き取り、温度22℃±1℃、湿度50%±5%の部屋内で20min静座する。 Here, the test device was a LAB test device spectrophotometer CM2600d (Minolta, Osaka, Japan). Before the test, the subject thoroughly washed his face, wiped it off with a tissue, and was heated at a temperature of 22 ° C. ± 1 ° C. and a humidity of 50%. Sit in a ± 5% room for 20 minutes.
我々の分散分析によれば、実施例1の試薬および実施例7の試薬はその他の各処理と高い有意差が認められ、本発明の共培養は、老化および色素沈着を取り消す生理活性物質の増加に有益であることを説明する。また、特に、共培養に対して適切な添加時間があることが比較的に重要である。実施例2〜6、8〜9の間は有意差が認められない(図1)。 According to our analysis of variance, the reagent of Example 1 and the reagent of Example 7 showed a significant difference from each of the other treatments, and the co-culture of the present invention showed an increase in bioactive substances that cancel aging and pigmentation. Explain that it is useful. It is also relatively important that there is an appropriate addition time, especially for the co-culture. No significant difference is observed between Examples 2 to 6 and 8 to 9 (FIG. 1).
我々はヒト皮膚細胞試験から、該原材料(実施例1または7)の添加量の増加に伴い細胞の生存能力が増加し(濃度1.25%〜12%)、従って該原材料は皮膚細胞の増殖再生能力を向上させることが分かった。逆に、同様な実施例2〜6、8〜9の原材料に対して同じく濃度を添加することは、細胞の生存能力を増加させず、一部は、例えば、実施例8〜9では逆に細胞の生存能力を低下させている。これに対する合理的な解釈は以下の通りである。皮膚の正常な再生サイクルは3〜4週間であり、細胞の増殖再生を促進することは皮膚の表皮層の新陳代謝を促進することによって、老化および色素沈着の角質を消去し、皮膚の外観に黄み消去の効果を持たせることができる。皮膚細胞の増殖再生能力を向上させる原因については、分析および試験によれば、該原材料には大量の多糖体、多価フェノール、アミノ酸などの細胞栄養成分が含有され、これらの栄養成分は細胞の増殖および再生に役立ち、細胞の生存能力を向上させる。これは、さらに、共培養発酵方法において、2種類の菌の混合のタイミングは特に重要であり、適切なタイミングの選択は一部の有益な生理活性物質の生産に役立ち、逆の場合、一部の有害物質が生成され、またはある症状に対して有害の物質を生成する可能性がある。 We have shown from human skin cell tests that cell viability increased (concentration 1.25% to 12%) with increasing amounts of the raw material (Examples 1 or 7), thus the raw material was It has been found that the reproduction ability is improved. Conversely, adding the same concentration to the raw materials of similar Examples 2-6, 8-9 does not increase the viability of the cells, and some are, for example, reversed in Examples 8-9. Decreases cell viability. The reasonable interpretation for this is as follows. The normal renewal cycle of the skin is 3-4 weeks, and promoting cell proliferation and renewal promotes metabolism of the epidermal layer of the skin, eliminating keratin of aging and pigmentation and yellowing the appearance of the skin. Only the effect of erasure can be provided. According to analysis and tests, the raw materials contain large amounts of cellular nutrients such as polysaccharides, polyhydric phenols, amino acids, etc. Helps with growth and regeneration, improves cell viability. This is further because in a co-culture fermentation process, the timing of the mixing of the two bacteria is particularly important, and the selection of the appropriate timing helps to produce some beneficial bioactive substances, and vice versa. Of harmful substances may be produced, or may produce harmful substances for certain symptoms.
(実施例14)
〔皮膚製剤の消炎試験〕
<消炎効果試験>
年齢15〜35歳のにきび(にきびレベル3〜4)がある患者3×160=480名(各グループに男女それぞれ80名)を選んで試験し、実施例1、8により得られた発酵生成物に対して試験を行った。
(Example 14)
(Anti-inflammatory test of skin preparation)
<Anti-inflammatory effect test>
3 x 160 = 480 patients with acne (acne levels 3-4) aged 15 to 35 years old (80 men and women in each group) were selected and tested, and the fermentation products obtained in Examples 1 and 8 Were tested.
<使用方法>
洗顔後、毎朝晩2回に分けて実施例1、8の発酵生成物を使用し(滅菌水で調製した15%の発酵生成物の皮膚製剤)、滅菌水を対照として、10日間連続して使用し、患部の発赤、腫れ、皮膚損傷の度合いを観察し、専門家の採点を基準として(0〜4点でにきびの深刻程度をつけ、0−にきびが認められない、1−軽いにきびがあり、ブラックヘッドが散在且つ多発し、散在性炎症性にきびがある;2−中間程度のにきびがあり、表在膿疱、炎症性にきびの箇所が多く、顔に限られている;3−重度、深在性炎症性にきびが認められる;4−重度、嚢胞、瘢痕が形成されやすい)評価した。
<How to use>
After washing the face, the fermented products of Examples 1 and 8 were used twice a day every morning and evening (a skin preparation of a 15% fermented product prepared with sterilized water), and the sterilized water was used as a control for 10 consecutive days. Use and observe the degree of redness, swelling and skin damage of the affected area. Based on the scoring by a professional (0 to 4 points, the degree of acne is serious, 0- acne is not recognized, 1- light acne Yes, sporadic and frequent blackheads, with sporadic inflammatory acne; 2-moderate acne, superficial pustules, many inflammatory acne spots, limited to face; 3-severe, (Deep inflammatory acne is observed; 4-severe, cysts, scars are likely to form)).
具体的なデータは下記の通りである。実施例1の発酵生成物は、にきびのレベルを顕著に低下させることができ、ここで、75名の女性は使用前のレベル3または4から10日間使用した後のレベル0〜1に変化され、50名の女性はレベル0に変化し、男性患者は、68人が使用前のレベル4から使用後のレベル1に変化した。明らかな変化がない人は、その他の原因によるにきびであるか効果がない。しかし、同じ方法を採用する場合、実施例2〜6の発酵生成物の消炎効果から見て、使用前および使用後、にきびレベルには明らかな変化がなく、実施例3および4を使用した患者は、女性の6名のみがレベル3からレベル1に変化し、男性は4名のみがレベル4からレベル1に変化した。実施例8の発酵生成物を採用した消炎効果から見て、一定の消炎効果を有するが、効果は明らかでなく、80名の女性患者のうち7名のみがレベル3からレベル1に変化し、80名の男性患者は6名のみがレベル4からレベル1に変化した。人体実験の結果から、実施例1は比較例2〜6、8〜9に比べてにきびに対する抑制および消炎効果がよりよく、効果はさらに明らかであり、実施例8における消炎効果と互いに適合し、滅菌水にも明らかな変化がないことが明らかになった。 Specific data is as follows. The fermented product of Example 1 can significantly reduce the level of acne, where 75 women are converted from level 3 or 4 before use to levels 0-1 after 10 days of use. , 50 women changed to level 0 and 68 male patients changed from level 4 before use to level 1 after use. Those who have no apparent change are acne due to other causes or ineffective. However, when the same method is adopted, there is no apparent change in the acne level before and after use in view of the anti-inflammatory effect of the fermentation products of Examples 2 to 6, and the patients using Examples 3 and 4 Showed that only six women changed from level 3 to level 1 and only four men changed from level 4 to level 1. In view of the anti-inflammatory effect employing the fermentation product of Example 8, it has a certain anti-inflammatory effect, but the effect is not clear, only 7 out of 80 female patients changed from level 3 to level 1, Of the 80 male patients, only 6 changed from level 4 to level 1. From the results of human body experiments, Example 1 has better suppression and anti-inflammatory effects on acne than Comparative Examples 2 to 6 and 8 to 9, and the effect is more apparent, and is compatible with the anti-inflammatory effect in Example 8, It was found that there was no apparent change in the sterilized water.
本明細書における方法を説明するための用語および表現方式は唯一且つ一定のものではなく、これらの用語および表現方式を使用して本発明または特徴を説明する如何なる同じ意味の表現方式を排除しようとする意図がなく、本発明が指定の範囲内の様々な表現方式を認める。従って、我々は本明細書において本発明が様々な具体的な解決手段および任意の特徴に対する説明によって明瞭に展開されたと考えるが、本明細書に開示された設計の表現方式を変更するにはさらに経験のある専門技術者に頼らなければならず、これらの変更は本発明に付属する声明と一致しなければならない。文章、特許、特許の適用はすべてのその他のテキストの内容および本明細書に言及され引証された有用な電子情報と結合されたものであり、必ず完全な内容として参考すべきであり、そのうちの如何なる部分を発表する時は特別にこの点を明示しなければならない。出願人は如何なるまたは全てのこれらの文章、特許、特許の適用またはその他のテキストの情報および材料を該出願書類に編入し本明細書が開示された一部とする権利を有する。 The terms and expressions used to describe the methods herein are not unique and specific, and it is intended that these terms and expressions be used to exclude any equivalent expression that describes the invention or features. The present invention recognizes various expression schemes within a specified range without intending to do so. Therefore, while we believe that the invention has been elucidated herein with an explanation of various specific solutions and optional features, further modifications to the presentation of the design disclosed herein are required. Relying on an experienced professional should make these changes consistent with the statement accompanying the present invention. The text, patent, and application of the patent are combined with all other textual content and useful electronic information referred to and substantiated herein, and should be referred to as complete content only, This point must be clearly indicated when any part is announced. Applicant reserves the right to incorporate any or all of these texts, patents, patent applications or other textual information and materials into the application and make this specification part of the disclosure.
Claims (7)
まず、サッカロマイセス・セレビシエを20〜30℃、酸性条件において1回または複数回発酵させ、酵母菌を増殖させるステップ(1)と、
酵母菌が対数増殖期後期になってからさらに温度を55〜65℃に昇温させた後の0日または1日後に、サーマス・サーモフィラスを接種し、アルカリ条件において第2回発酵させ、発酵生成物を得るステップ(2)と、
を含むことを特徴とするサーマス・サーモフィラスと酵母菌との組合せの発酵方法。 Fermentation method of the combination of thermus thermophilus and yeast,
First, a step (1) of fermenting Saccharomyces cerevisiae once or plural times under acidic conditions at 20 to 30 ° C. to grow yeast cells;
0 or 1 day after the yeast was further raised to a temperature of 55 to 65 ° C. after the late logarithmic growth phase, inoculated with Thermos thermophilus, fermented a second time under alkaline conditions, and fermented. Obtaining a thing (2);
A fermentation method for a combination of Thermos thermophilus and a yeast, comprising:
使用されるサーマス・サーモフィラスHB27はアメリカン・タイプ・カルチャー・コレクション(ATCC)から購入されたもので、保存番号はBAA−163である、ことを特徴とする請求項1〜4のいずれか1項に記載の方法。 The strain of Saccharomyces cerevisiae is CICC1596, which was purchased from the China Industrial Microbial Species Preservation and Management Center, and the storage number is CICC1596;
The method according to any one of claims 1 to 4, wherein the Thermus thermophilus HB27 used is purchased from the American Type Culture Collection (ATCC) and has a storage number BAA-163. The described method.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810358237.5A CN108517345B (en) | 2018-04-20 | 2018-04-20 | Thermophilic thermus strain and microzyme combined fermentation method |
CN201810358237.5 | 2018-04-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019187409A JP2019187409A (en) | 2019-10-31 |
JP6669822B2 true JP6669822B2 (en) | 2020-03-18 |
Family
ID=63429837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018150901A Active JP6669822B2 (en) | 2018-04-20 | 2018-08-09 | Fermentation method of the combination of Thermos thermophilus and yeast |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6669822B2 (en) |
CN (1) | CN108517345B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017094027A (en) * | 2015-11-14 | 2017-06-01 | 株式会社三洋物産 | Game machine |
CN111297792B (en) * | 2020-02-26 | 2021-07-27 | 广州一一生物技术有限公司 | Amino acid surfactant composition containing symbiotic bacteria combined fermentation product, facial cleanser and preparation method of facial cleanser |
CN113952284B (en) * | 2020-02-26 | 2023-08-01 | 广州留今科学研究有限公司 | Symbiotic bacteria combined fermentation product and preparation method and application thereof |
CN113616584B (en) * | 2020-05-08 | 2023-05-05 | 上海中翊日化有限公司 | Anti-inflammatory skin care product composition containing double-fungus fermentation product and active grape seed extract for resisting urban pollution |
CN111778189A (en) * | 2020-07-15 | 2020-10-16 | 曲靖凯美冠有机肥生产有限公司 | Compound fermentation strain formula, fermentation process and compound device thereof |
CN112618464A (en) * | 2021-01-28 | 2021-04-09 | 广州市玉鑫化妆品有限公司 | Preparation method of yeast rice fermentation product filtrate |
CN114525319A (en) * | 2022-03-11 | 2022-05-24 | 杭州优玛达生物科技有限公司 | Heat shock protein-ectoin composition and preparation method and application thereof |
CN114592023B (en) * | 2022-03-31 | 2023-03-24 | 杭州优玛达生物科技有限公司 | Cell lysis self-assembly polypeptide compound, self-assembly method, self-assembly polypeptide preparation and application |
CN114525230B (en) * | 2022-03-31 | 2024-04-09 | 杭州优玛达生物科技有限公司 | Fermentation culture and fermentation method of thermophilic thermus strain using fermentation culture |
CN114574403A (en) * | 2022-04-13 | 2022-06-03 | 广东药科大学 | Method for preparing thermophilic thermus strain fermentation product by utilizing rice bran enzyme hydrolysate |
CN115678805B (en) * | 2022-11-02 | 2023-06-13 | 稀物集(广州)生物科技有限公司 | Preparation method and application of tricholoma matsutake yeast fermentation liquor with repairing and anti-aging effects |
CN116497077A (en) * | 2023-05-12 | 2023-07-28 | 广东药科大学 | Method for preparing thermophilic thermus fermentation product by using tremella extract |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101433502A (en) * | 2007-11-14 | 2009-05-20 | 高宝化妆品(中国)有限公司 | Biological enzyme sun block composition |
CN103173371B (en) * | 2011-12-20 | 2014-07-02 | 辽宁威兰生物技术有限责任公司 | Production of saccharomyces cerevisiae and lactobacillus acidophilus composite microbe preparation used for feed |
CN105434319B (en) * | 2015-12-07 | 2018-09-14 | 华南理工大学 | A kind of cosmetics and preparation method thereof based on phaffiafhodozyma raw material |
CN107184411B (en) * | 2017-04-21 | 2019-02-22 | 韩后化妆品股份有限公司 | A kind of tender factor of Compound Water, the preparation method of cosmetics and cosmetics |
CN107362129B (en) * | 2017-08-23 | 2019-10-18 | 广东丸美生物技术股份有限公司 | Skin matrix, preparation method and applications and cosmetics and preparation method thereof |
-
2018
- 2018-04-20 CN CN201810358237.5A patent/CN108517345B/en active Active
- 2018-08-09 JP JP2018150901A patent/JP6669822B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108517345B (en) | 2021-07-27 |
JP2019187409A (en) | 2019-10-31 |
CN108517345A (en) | 2018-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6669822B2 (en) | Fermentation method of the combination of Thermos thermophilus and yeast | |
JP6793692B2 (en) | Uses of fermentation products in combination with thermath thermophilus and yeast | |
US20230193196A1 (en) | Bifidobacterium animalis subsp. lactis gfc-b09 strain and cosmetic composition containing same | |
CN105560097A (en) | Peony enzymes and preparation method and application thereof | |
CN110592151A (en) | Fermentation liquor with high content of gamma-aminobutyric acid produced by lactic acid bacteria and application of fermentation liquor in cosmetics | |
CN111973498A (en) | Ganoderma lucidum fermentation product and preparation method and application thereof | |
CN111534455B (en) | Preparation of lactobacillus sporolysis product and application of lactobacillus sporolysis product in cosmetics | |
CN112999127B (en) | Gentiana scabra bunge compound enzyme and preparation method and application thereof | |
CN106726949B (en) | Grape seed fermentation raw stock cosmetic and preparation method and application thereof | |
CN102851259A (en) | Preparation method of antioxidant | |
CN111514084B (en) | Rice fermentation product humectant and preparation method and application thereof | |
CN115569096B (en) | Camellia flower fermentation filtrate and fermentation process | |
CN115141863B (en) | Method for preparing schizophyllum commune fermentation product by adopting composite whole plant culture medium | |
KR20170031578A (en) | Preparation method of osmotic enzyme fermentation product using dendranthema zawadskii, the fermentation product prepared thereby and cosmetic, food or pharmaceutical composition comprising the same | |
CN115634163A (en) | Whitening skin-care essence milk and preparation method thereof | |
CN115337238A (en) | Preparation method and application of coffee fermented product | |
CN115364025A (en) | Composition with scalp care effect and preparation method and application thereof | |
CN111544352B (en) | Tremella-ganoderma lucidum composite fermentation product, cosmetic composition with anti-aging effect and preparation method and application thereof | |
WO2021217693A1 (en) | Use of symbiotic fermentation product of hydrolyzed candida and japanese sake yeast | |
CN113952284B (en) | Symbiotic bacteria combined fermentation product and preparation method and application thereof | |
CN108888573B (en) | Soothing and moisturizing cream and preparation method thereof | |
CN108969430B (en) | Application of American ginseng fermentation liquor as skin care product or skin care product additive | |
CN111568799A (en) | Application of holothurian glycolysis element in whitening products | |
CN113332192B (en) | Callicarpa japonica fruit fermentation product and preparation method and application thereof | |
KR20210105234A (en) | The Development of Cosmeceutical Products for Whitening and Anti-wrinkle Cosmetic Agent by using bracken(Pteridium aquilinum) bio -conversion substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180809 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190730 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190925 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200108 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200227 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6669822 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |